NHI Files Q3 2024 10-Q Report

Ticker: NHI · Form: 10-Q · Filed: Nov 5, 2024 · CIK: 877860

National Health Investors INC 10-Q Filing Summary
FieldDetail
CompanyNational Health Investors INC (NHI)
Form Type10-Q
Filed DateNov 5, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, real-estate, REIT

TL;DR

NHI's Q3 2024 10-Q is in. Get the deets on their real estate portfolio performance.

AI Summary

National Health Investors Inc. (NHI) filed its 10-Q for the period ending September 30, 2024. The company, a real estate investment trust, reported its financial performance for the third quarter and the first nine months of the year. Key financial data and operational details are presented in this filing.

Why It Matters

This filing provides investors with a detailed look at National Health Investors' financial health and operational performance for the third quarter of 2024, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing (10-Q) and does not inherently present new risks.

Key Numbers

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240930, meaning the filing covers the period ending September 30, 2024.

When was this 10-Q filed with the SEC?

This 10-Q was filed on 20241105.

What is the Standard Industrial Classification (SIC) code for National Health Investors Inc.?

The SIC code for National Health Investors Inc. is 6798, which corresponds to Real Estate Investment Trusts.

What is the business address of National Health Investors Inc.?

The business address is 222 ROBERT ROSE DRIVE, MURFREESBORO, TN 37129.

What is the fiscal year end for National Health Investors Inc.?

The fiscal year end for National Health Investors Inc. is 1231.

Filing Stats: 4,678 words · 19 min read · ~16 pages · Grade level 16 · Accepted 2024-11-05 16:05:50

Key Financial Figures

Filing Documents

Financial Information

Part I. Financial Information

Financial Statements

Item 1. Financial Statements 3

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. 34

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk. 61

Controls and Procedures

Item 4. Controls and Procedures. 62

Other Information

Part II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 63

Risk Factors

Item 1A. Risk Factors 63

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 65

Other Information

Item 5. Other Information 65

Exhibits

Item 6. Exhibits 66

Signatures

Signatures 67 2 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements NATIONAL HEALTH INVESTORS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) September 30, 2024 December 31, 2023 (unaudited) Assets: Real estate properties: Land $ 181,173 $ 180,749 Buildings and improvements 2,627,928 2,593,696 Construction in progress 11,329 5,913 2,820,430 2,780,358 Less accumulated depreciation ( 723,606 ) ( 673,276 ) Real estate properties, net 2,096,824 2,107,082 Mortgage and other notes receivable, net of reserve of $ 19,411 and $ 15,476 , respectively 232,550 245,271 Cash and cash equivalents 15,550 22,347 Straight-line rent receivable 86,334 84,713 Assets held for sale, net 5,669 5,004 Other assets, net 23,163 24,063 Total Assets (a) $ 2,460,090 $ 2,488,480 Liabilities and Stockholders' Equity: Debt $ 1,136,302 $ 1,135,051 Accounts payable and accrued expenses 32,508 34,304 Dividends payable 39,260 39,069 Deferred income 4,612 6,009 Total Liabilities (a) 1,212,682 1,214,433 Commitments and contingencies Redeemable noncontrolling interest 8,925 9,656 National Health Investors, Inc. Stockholders' Equity: Common stock, $ 0.01 par value per share, 100,000,000 shares authorized; 43,622,064 and 43,409,841 shares issued and outstanding, respectively 436 434 Capital in excess of par value 1,601,450 1,603,757 Retained earnings 2,561,587 2,466,844 Cumulative dividends ( 2,934,523 ) ( 2,817,083 ) Total National Health Investors, Inc. Stockholders' Equity 1,228,950 1,253,952 Noncontrolling interests 9,533 10,439 Total Equity 1,238,483 1,264,391 Total Liabilities and Equity $ 2,460,090 $ 2,488,480 (a) The Condensed Consolidated Balance Sheets include the following amounts related to our consolidated variable interest entities: $ 507.1 million and $ 513.2 million of Real estate properties, net; $ 6.9 million and $ 10.9 million of Cash and cash equivalents; $ 9.9 million and $ 9.7 million of Straight-line rent receivable; $ 8.1 mil

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing